Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
>CME/CNE ARTICLE: Severity Grading in Multiple Sclerosis: A Proposal.
Hereditary and metabolic myelopathies.
Intravenously infused F3.Olig2 improve memory deficit via restoring demyelination in the aged hippocampus following experimental ischemic stroke.
Inflammaging and Frailty Status Do Not Result in an Increased Extracellular Vesicle Concentration in Circulation.
Effectiveness and safety of natalizumab in real-world clinical practice: Review of observational studies.
ROCK inhibition enhances neurite outgrowth in neural stem cells by upregulating YAP expression in vitro.
Novel fMRI working memory paradigm accurately detects cognitive impairment in multiple sclerosis.
A microglial hypothesis of globoid cell leukodystrophy pathology.
Shared decision-making in multiple sclerosis: A review.
Safety and tolerability of fingolimod in patients with relapsing-remitting multiple sclerosis: results of an open-label clinical trial in Italy.
Acorda Therapeutics announces initiation of AMPYRA® proof-of-concept study in patients with post-stroke deficits
The Pharmacological Effects and Mechanism of Tripterygium wilfordii Hook F in Central Nervous System Autoimmunity.
Genetic Leukoencephalopathies in Adults.
Myelin oligodendrocyte glycoprotein induces incomplete tolerance of CD4(+) T cells specific for both a myelin and a neuronal self-antigen in mice.
Anthraquinones As Pharmacological Tools and Drugs.
Antibodies to myelin basic protein are associated with cognitive decline after stroke.
Fatigue in Parkinson's disease: report from a mutidisciplinary symposium.
miRNAs As Emerging Regulators of Oligodendrocyte Development and Differentiation.
Congenic mapping confirms a locus on rat chromosome 10 conferring strong protection against myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis.
Virtual reality in multiple sclerosis - A systematic review.
Myelin-targeted, texaphyrin-based multimodal imaging agent for magnetic resonance and optical imaging.
Predictive and reactive grip force responses to rapid load increases in people with multiple sclerosis.
Hippocampal and Deep Gray Matter Nuclei Atrophy Is Relevant for Explaining Cognitive Impairment in MS: A Multicenter Study.
The emerging role of p38 MAP kinase in multiple sclerosis and its models.
Human Endogenous Retrovirus and Neuroinflammation in Chronic Inflammatory Demyelinating Polyradiculoneuropathy.
Pages
« first
‹ previous
…
781
782
783
784
785
786
787
788
789
…
next ›
last »